New lens aims to sharpen vision after cataract surgery

NCT ID NCT07648355

Recruiting now Symptom relief Sponsor: OVO LASIK + Lens Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new type of lens called Clareon TruPlus, used during cataract surgery to replace the eye's natural lens. Researchers want to see how well it improves vision and how satisfied patients are up to 3 months after the procedure. The study involves 40 adults over 40 years old who are having cataract surgery and have otherwise healthy eyes. They will be checked for vision sharpness and asked to fill out a questionnaire about their experience.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Clareon TruPlus intraocular lens
What this could lead to: If successful, this lens could improve vision and satisfaction after cataract surgery, offering a new option for patients.
What could go wrong: This is a small, early study with only 40 participants and no comparison group, so results may not apply to everyone. Risks are typical for cataract surgery, such as infection or lens issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT

Contacts and locations

Locations

Ovo Lasik + Lens
RECRUITING

Saint Louis Park, Minnesota, 55416, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.